Calcitonin gene-related peptide (CGRP) plays a pivotal role in the pathophysiology of migraine and is an important therapeutic target. Monoclonal antibodies that inhibit CGRP binding to its receptor ...

BARCELONA — Patients with migraine are less likely to respond to CGRP monoclonal antibody (mAb) preventive treatments if they have certain psychiatric disorders, a new study shows. Italian researchers ...

Advancements in migraine research over the past few decades have led researchers to identify the possible role of calcitonin gene-related peptide (CGRP) in migraine pathophysiology. CGRP is a ...

For Cherise Irons, chocolate, red wine, and aged cheeses are dangerous. So are certain sounds, perfumes and other strong scents, cold weather, and thunderstorms. Stress and lack of sleep, too. She ...

When women suffer migraine attacks, it is often just before or during their monthly period. A team of researchers from Charité – Universitätsmedizin Berlin has now identified a possible explanation.

The approval of medicines called “CGRP antagonists” has led to big changes in how migraines are managed. These medicines work in a different way than older medicines to treat or prevent migraine. The ...

Migraines are far more than just bad headaches. They are a complex, chronic neurological condition that affects more than a billion people worldwide and ranks among the top causes of disability across ...

If a condition that disables one in seven adults were perceived as a ‘men’s disease,’ it would almost certainly receive more ...

One class of drugs has already found success in treating the painful, disorienting and common attacks. Excitement is building about a slew of additional drug targets. By Amber Dance/Knowable Magazine ...